Download presentation
Presentation is loading. Please wait.
Published byJemimah Potter Modified over 6 years ago
1
A Feasibility and Safety Study of Bronchoscopic Thermal Vapor Ablation: A Novel Emphysema Therapy
Gregory I. Snell, MD, Peter Hopkins, MBBS, Glen Westall, PhD, Lynda Holsworth, BNurs, Anne Carle, RN, Trevor J. Williams, MD The Annals of Thoracic Surgery Volume 88, Issue 6, Pages (December 2009) DOI: /j.athoracsur Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Uptake Medical bronchial thermal vapor ablation generator and catheter (Uptake Medical Corporation, Seattle, WA). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Individual changes in treated lobar volume, comparing baseline (0 months), 3 months, and 6 months in 11 patients. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Chest computed tomography transverse slice example of left-sided unilateral bronchial thermal vapor ablation demonstrates loss of the target left upper lobe volume at (A) baseline, (B) 3 months, and (C) 6 months. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
5
Fig 4 Individual changes in St. George Respiratory Questionnaire Total Sccores comparing baseline (0 months) and 6 months. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
6
Fig 5 Individual forced expiratory volume in 1 second (FEV1), residual volume (RV), and diffusion capacity of the lung for carbon monoxide (Dlco) results at baseline (0 months) and at 1, 3, and 6 months in 11 patients. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.